GTP Bioways CDMO is a CDMO offering expert services for process development and cGMP manufacturing of antibodies and proteins using both mammalian and microbial expression systems. Founded in 2000, the company has gathered over 20 years of experience in developing custom processes for even the most challenging proteins and monoclonal antibodies (mAbs).

GTP Tech is part of GTP Bioways group that offers end-to-end CDMO services for the manufacturing of therapeutics, including:

R&D services:
- Developability and manufacturability assessment
- Batches manufacturing for efficacy or non-GLP toxicology studies

Process development:
- Cell line and strain development
- USP development
- DSP development
- Analytical methods development
- Custom ELISA development for HCPs analysis
- Pre-formulation, formulation and stability assessment
- Manufacturing of pre-clinical non-GMP batches

DS manufacturing:
- MCB/WCB manufacturing
- GMP batch manufacturing (10 to 1000L for mammalian and 350L for microbial)
- Stability studies
- Analytical methods validation

DP manufacturing:
- F&F of vials and pre-filled syringes (batches up to 10 000 units)
- Stability studies
- Analytical methods qualification

Support for IMPD